Canada's EcoSynthetix Q3 sales fall 38% on lower volumes, macroeconomic conditions

By Reuters News


Overview

  • Canada renewable chemicals firm's Q3 sales fell 38% yr/yr on lower volumes

  • Q3 adjusted EBITDA was nearly flat as lower gross profit offset by reduced operating costs

  • Company repurchased and cancelled 23,000 shares in Q3 under normal course issuer bid


Outlook

  • EcoSynthetix says macro dynamics in key end markets continue to weigh on sales volumes

  • Company prioritizes driving adoption within existing and new customers to return to growth

  • EcoSynthetix continues to work with key accounts to support higher usage of its biopolymers


Result Drivers

  • LOWER SALES VOLUMES - Co said Q3 sales fell due to reduced volumes in key end markets and challenging macroeconomic conditions

  • SLOWER CUSTOMER ADOPTION - Co said rate of adoption of its biopolymers was slower than anticipated, with strategic accounts using products at reduced levels

  • HIGHER AVERAGE SELLING PRICE - Co said higher average selling price, driven by product mix and FX, partially offset volume declines


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

$3.60 mln

Q3 Adjusted EBITDA

$39,437


Reuters Recommended Reads

  • Nov 2 - Canada's proposed new biofuels rules only a first step, industry says

  • Nov 3 - Rayonier Advanced Materials Q3 sales and EBITDA miss estimates on tariffs, impairments

  • Nov 2 - Chemours Q3 adjusted profit misses estimates despite titanium pricing gains


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk